Amorphous AI

Cover Block

Attribute	Value
Name	Amorphous AI
Tagline	Multi-agent AI (Striata) that processes unstructured clinical text into standards-compliant insights for healthcare. [SNOMED International, post-2024]
Headquarters	Oxford, United Kingdom [Companies House, 2024]
Stage	Pre-Seed
Business Model	SaaS
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale
Funding Label	Undisclosed (total disclosed ~$3,300,000) [LinkedIn Nikita Trojanskis]

Links

• Website. https://amorphous.health/
• LinkedIn. https://www.linkedin.com/company/amorphous-ai-oxford
• X / Twitter. https://x.com/nikitatr1?lang=en

What an Investor Needs First

Amorphous AI is an early-stage Oxford-based venture developing an AI system to transform unstructured clinical notes into queryable, standards-compliant data. The company's core product, Striata, is a multi-agent AI pipeline that ingests raw hospital text, de-identifies it, maps clinical concepts to ontologies like SNOMED CT and LOINC, and generates insights for real-world evidence and operational decisions [SNOMED International, post-2024] [Amorphous AI, Unknown].

Dylan Sandfelder is identified as co-founder and CTO. Nikita Trojanskis, a DPhil student in biology at the University of Oxford, is also associated with the company and is linked to a $3.3 million pre-seed financing round [University of Oxford Biology Department, Unknown] [LinkedIn, Unknown]. The company maintains a minimal public footprint, with recent corporate registrations in the UK and Latvia in 2024 [Companies House, 2024] [Lursoft, Sep 2024].

Data Accuracy: YELLOW -- Core product claims are sourced from the company and a standards body; team and funding details are partially corroborated but lack independent verification.

Taxonomy Snapshot

Axis	Classification
Stage	Pre-Seed
Business Model	SaaS
Industry / Vertical	Healthtech
Technology Type	AI / Machine Learning
Geography	Western Europe
Growth Profile	Venture Scale

Inside the Company

Amorphous AI operates in a state of significant public stealth. The company maintains two registered entities: AMORPHOUS AI LTD in the United Kingdom and SIA Amorphous AI in Latvia [Companies House, 2024] [Lursoft, Sep 2024].

Key personnel have been identified through public professional profiles. Dylan Sandfelder is listed as the co-founder and CTO on a personal website [Dylan Sandfelder personal site]. Nikita Trojanskis is associated with the company and linked to a $3.3 million pre-seed funding round [University of Oxford Biology Department] [LinkedIn, Nikita Trojanskis]. Edgars Labsvīrs has been associated with hiring activity for the company in Riga [LinkedIn, Edgars Labsvīrs].

Data Accuracy: YELLOW -- Key entity and personnel data sourced from official registries and LinkedIn; core product claim corroborated by SNOMED International.

Under the Hood

The company's product, Striata, is a multi-agent AI system designed to process unstructured clinical text. It ingests text from hospital sources, performs de-identification, and maps clinical concepts to standardized terminologies like SNOMED CT, LOINC, and ICD-10 [SNOMED International, post-2024]. The system is designed to automate the transformation of raw clinical notes into analysis-ready data for observational research and Real World Evidence generation [Amorphous AI, Unknown].

Data Accuracy: YELLOW -- Product claims are sourced from a third-party industry feature and a company whitepaper.

Market Research and Opportunity

The market for structuring and analyzing unstructured clinical data is expanding. The broader market for Real World Evidence solutions was valued at $1.9 billion in 2023, with a projected compound annual growth rate of 13.5% through 2030 [Grand View Research, 2024]. The healthcare natural language processing market was estimated at $2.7 billion in 2022 [MarketsandMarkets, 2023].

Metric	Value
Real World Evidence Solutions Market (2023)	$1.9B
Healthcare NLP Market (2022)	$2.7B

Data Accuracy: YELLOW -- Market sizing figures are from third-party analyst reports for analogous sectors.

Competition and Substitutes

Amorphous AI competes in a dense market for clinical natural language processing and Real World Evidence generation. Incumbents include EHR vendors like Epic and Cerner, and established health data platforms such as Tempus and Flatiron Health. Pure-play AI vendors like Verana Health, Komodo Health, and nference also compete in this space.

Amorphous AI's architectural focus on a fully automated, multi-agent system (Striata) aims to offer a cost and speed advantage over hybrid human-in-the-loop services [SNOMED International, post-2024].

Data Accuracy: YELLOW -- Competitive analysis is inferred from the broader market context.

Opportunity

If Amorphous AI can successfully automate the structuring of unstructured clinical text, it aims to capture a position in the real-world data market. The company's core proposition is to replace manual data processing teams with an automated AI system [Amorphous Technology Whitepaper].

Scenario	What happens	Catalyst
The Research Platform	Academic medical centers and CROs adopt Striata for observational studies.	A published, peer-reviewed validation study.
The Hospital Operating System	A major NHS trust or large US hospital system licenses the platform for operational dashboards.	A flagship deployment at a named hospital.

Data Accuracy: YELLOW -- Core product claims are sourced from the company's whitepaper and a SNOMED International feature page.

Sources

1. [SNOMED International, post-2024] SNOMED in Action: Amorphous AI | https://www.snomed.org/snomed-in-action/amorphous-ai
2. [Amorphous AI, Unknown] Amorphous Technology Whitepaper | https://amorphous.health/whitepaper
3. [Companies House, 2024] AMORPHOUS AI LTD | https://find-and-update.company-information.service.gov.uk/company/16979345
4. [Lursoft, Sep 2024] SIA Amorphous AI | https://company.lursoft.lv/en/amorphous-ai/40203592108
5. [Dylan Sandfelder personal site, Unknown] Dylan Sandfelder | https://dylansand.github.io/
6. [University of Oxford Biology Department, Unknown] Nikita Trojanskis | https://www.biology.ox.ac.uk/people/nikita-trojanskis
7. [LinkedIn, Nikita Trojanskis] Nikita Trojanskis | https://www.linkedin.com/in/nikita-trojanskis-078906146/
8. [LinkedIn, Edgars Labsvīrs] Edgars Labsvīrs | https://www.linkedin.com/in/edgars-labsv%C4%ABrs-74854a3b/
9. [Amorphous AI, Unknown] Amorphous AI Website | https://amorphous.health/